"Watch and wait" may seem safe—but with severe AS, it's a gamble. Once symptoms appear, the risk of sudden cardiac death increases sharply and the window for intervention narrows. Early detection and timely referral are critical to improving outcomes. The most at-risk patient is the one who seems fine, until they're not.
Patients from underserved groups—including women, individuals in lower-income households, and those from certain racial or ethnic backgrounds—are less likely to be diagnosed with severe AS or referred for treatment, putting them at greater risk for poor outcomes.
Dr. Thourani discusses the crucial necessity of promptly partnering with a Heart Valve Team.
Routine heart valve screenings and timely referral for an echocardiogram are crucial for accurately assessing disease severity. These steps guide critical clinical decisions and enable interventions that can prevent a rapid deterioration in patient health and save lives.
Severe AS can escalate quickly, putting patients at serious risk, often without warning.
Access practical tools and educational materials to support your clinical decision-making.
PP--US-9674 v2.0
By clicking this link, you understand that the website that you will be taken to is not controlled or endorsed by Edwards Lifesciences (“Edwards”), and Edwards does not own, control, or influence the content found on the third-party website. You also understand that Edwards does not own or control any first- or third-party advertising, marketing, or analytics technologies that may be on the third-party website.
Would you like to continue?
The content on ScreenHeartValveDisease.com/hcp is intended for healthcare professionals.